Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.

Oncotarget - 7 Feb 2017

Zhang Jing, Guo Lei, Liu Xiuyun, Li Wenbin, Ying Jianming

Abstract excerpt

This study was conducted to investigate the expression of MET in Chinese gastric adenocarcinoma cohort, the correlation between MET overexpression and clinical pathological features, HER2 expression and MET gene amplification. A total of 816 gastric adenocarcinoma patients were included and MET and HER2 immunohistochemical (IHC) staining were performed. IHC and dual-color silver in situ hybridization analysis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Amplification
Share to Gene Expression Regulation, Enzymologic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization

Share to Proto-Oncogene Proteins c-met

Share to Receptor, ErbB-2

Share to Stomach Neoplasms

Share to Tissue Array Analysis

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 28052014
DOI: 10.18632/oncotarget.14382
PMCID: PMC5354657

Genes

MET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.PMID 28052014Read ↗

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcomeSemantic proximity Read ↗

Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancerSemantic proximity Read ↗

Impact of MET amplification on gastric cancer: Possible roles as a novel prognostic marker and a potential therapeutic targetSemantic proximity Read ↗

Gastric cancer patient with c-MET amplification treated with crizotinib after failed multi-line treatment: A case report and literature reviewSemantic proximity Read ↗

<i>MET</i> amplification as a potential therapeutic target in gastric cancerSemantic proximity Read ↗

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinomaSemantic proximity Read ↗

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomasSemantic proximity Read ↗

Overexpression of MATN3 predicts poor prognosis of gastric adenocarcinoma: based on TCGA databaseSemantic proximity Read ↗

Forty‐nine gastric cancer cell lines with integrative genomic profiling for development of c‐MET inhibitorSemantic proximity Read ↗

Frequent Gene Amplification Predicts Poor Prognosis in Gastric CancerSemantic proximity Read ↗

Amplification of the c-<i>met,</i> c-<i>erbB</i>-2 and Epidermal Growth Factor Receptor Gene in Human Gastric Cancers: Correlation to Clinical FeaturesSemantic proximity Read ↗

MET overexpression and gene amplification: prevalence, clinico-pathological characteristics and prognostic significance in a large cohort of patients with surgically resected NSCLCSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.